Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZKSCAN4 Activators

ZKSCAN4 activators, in a theoretical context, would encompass chemicals that directly or indirectly facilitate the activation or enhance the function of Zinc Finger with KRAB and SCAN Domains 4. Direct activators would bind to ZKSCAN4, inducing a conformational change that promotes its DNA-binding activity or stabilizes its structure. However, in the absence of such direct activators, the focus shifts to indirect activators that influence transcriptional regulation and epigenetic modifications. The indirect activators of ZKSCAN4 primarily include compounds that modulate DNA methylation and histone modifications. These chemicals, such as 5-Azacytidine, Trichostatin A, and SAHA, can alter the epigenetic landscape, impacting the gene regulatory functions of ZKSCAN4. By changing the epigenetic marks on DNA or histones, they can modulate the accessibility of genomic regions where ZKSCAN4 might exert its regulatory effects. Furthermore, inhibitors targeting components of chromatin remodeling complexes, like EZH2 inhibitors or BRD4 inhibitors, also play a significant role. By modulating the activity of these complexes, they can indirectly influence the regulatory functions of ZKSCAN4.

Exploring the indirect activators of ZKSCAN4 is crucial for understanding the regulation of gene expression and epigenetic control. Since ZKSCAN4 is involved in DNA binding and gene regulation, influencing its activity has implications in deciphering gene expression patterns, cellular differentiation, and disease mechanisms, particularly those related to dysregulated gene expression. The study of these indirect activators sheds light on the complex network of gene regulation and epigenetic control, highlighting the intricate interplay between transcription factors and the epigenetic landscape. This exploration contributes to our basic biological understanding and has implications for developing strategies targeting disorders of gene regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

A small molecule that inhibits BET bromodomain proteins, potentially impacting ZKSCAN4's role in gene regulation.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

A broad-spectrum histone deacetylase inhibitor, potentially influencing the epigenetic regulation of ZKSCAN4 target genes.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$218.00
$634.00
1
(1)

A histone deacetylase inhibitor, which can alter chromatin structure and potentially affect the function of ZKSCAN4.

GSK126

1346574-57-9sc-490133
sc-490133A
sc-490133B
1 mg
5 mg
10 mg
$92.00
$243.00
$306.00
(0)

A specific inhibitor of EZH2, potentially impacting the epigenetic regulation mechanisms involving ZKSCAN4.

Mocetinostat

726169-73-9sc-364539
sc-364539B
sc-364539A
5 mg
10 mg
50 mg
$214.00
$247.00
$1463.00
2
(1)

A histone deacetylase inhibitor, which might influence ZKSCAN4 activity by altering chromatin accessibility.